| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/13/2006 | CN1274342C Preparation for external use of Chinese traditional medicine for treating gout and preparation method |
| 09/13/2006 | CN1274335C Medicine for treating piles and its preparing process |
| 09/13/2006 | CN1274331C Mixture for treating acute condyloma |
| 09/13/2006 | CN1274326C Composite formulation for treating bronchial asthma |
| 09/13/2006 | CN1274319C Use of phytosterone component in Radix Rhapontici |
| 09/13/2006 | CN1274314C Health care food for defatting |
| 09/13/2006 | CN1274313C Preparation method of clindamycin phosphate powder injection |
| 09/13/2006 | CN1274312C Use of New Zealand vitexin-1 in preparing antiviral medicine |
| 09/13/2006 | CN1274311C Application and formulation of dammarane type gen-seng low valence alcohol derivative |
| 09/13/2006 | CN1274310C Paste agent of penetrating through skin for treating arthritid and preparation method |
| 09/13/2006 | CN1274309C Enteric-coated formulation of glycyrrhizic acid and its salt and its preparing method |
| 09/13/2006 | CN1274308C Prostatic atrophy antiphlogistic injection liquid |
| 09/13/2006 | CN1274307C Use of alkaloid compounds in preparing medicine |
| 09/13/2006 | CN1274306C Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use |
| 09/13/2006 | CN1274305C Pharmaceutical composition with combined active agents and methods for using the same |
| 09/13/2006 | CN1274304C Etomidate fatty emulsion injection preparation method |
| 09/13/2006 | CN1274303C Use of compound and its derivatives in preparing medicine for treating cancer |
| 09/13/2006 | CN1274302C Blood fat reducing composition containing avatatin and its use |
| 09/13/2006 | CN1274301C Application of alpha benzyl, beta benzyl and gamma butyrolactone for preparing medicine of lowering blood sugar |
| 09/13/2006 | CN1274300C Combination of medication in use for improving dissolution of curcumin and bioavailability as well as preparation method |
| 09/13/2006 | CN1274299C Doxy rhodol magnetic microglobule and its making method |
| 09/13/2006 | CN1274297C Composition and drug form for curing oral nosomycosis |
| 09/13/2006 | CN1274293C Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent |
| 09/13/2006 | CN1274291C Compositions and methods for treating hyperpigmentation |
| 09/13/2006 | CN1274243C Hair tonic amino acid and its preparation method |
| 09/12/2006 | US7105705 E.g., dodecahydroadhyperforin and acetyloctahydroadhyperforin, for use in the treatment of depression and Alzheimer's disease |
| 09/12/2006 | US7105701 Multibinding compounds for agonists for phenolic derivatives for adrenergic receptors with carriers |
| 09/12/2006 | US7105699 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide |
| 09/12/2006 | US7105695 Anticarcinogenic agents formed by phosphorylation |
| 09/12/2006 | US7105685 Viricides treating Human Immunodeficiency Viruses; antitumor agents |
| 09/12/2006 | US7105682 Substituted amine derivatives and methods of use |
| 09/12/2006 | US7105676 Tetrahydropyridoethers |
| 09/12/2006 | US7105675 Analgesics with use of treating pain and as immunomodulators and for treatment of drug dependence |
| 09/12/2006 | US7105673 Cardioprotective phosphonates and malonates |
| 09/12/2006 | US7105671 2-Substituted phenyl,3-polar ring,N-heroaromatic propion-amides, e.g., 1-(2-(3,4-Dichlorophenyl)-3-(tetrahydro-furan-2-yl)-propionyl)-3- methylurea; antidiabetic agents; increase the flux of glucose metabolism in beta-cells and hepatocytes |
| 09/12/2006 | US7105670 Intermediates useful in the preparation of diaminothiazoles |
| 09/12/2006 | US7105669 Quinazoline derivatives |
| 09/12/2006 | US7105668 Methods and compositions utilizing quinazolinones |
| 09/12/2006 | US7105667 Fused heterocyclic compounds and use thereof |
| 09/12/2006 | US7105665 Compound for treatment of diarrhea, nervous system disorders such as Alzheimers and asthma in mammals |
| 09/12/2006 | US7105663 Derivatives of pyrimido[6,1-a]isoquinolin-4-one |
| 09/12/2006 | US7105648 Oligomers substituted by phosphite acid ester, phosphonic acid or carbaborane functions and the corresponding PNA monomers |
| 09/12/2006 | US7105644 Secreted protein HHTLF25 antibodies |
| 09/12/2006 | US7105637 Kits for detection/diagnosis of Smith-Lemli-Optiz syndrome |
| 09/12/2006 | US7105577 Antimicrobial method using a hydroxydiphenyl ether compound |
| 09/12/2006 | US7105576 Synergistic effects of nuclear transcription factor NF-κB inhibitors and anti-neoplastic agents |
| 09/12/2006 | US7105575 Methods for the treatment of neuro- disorders using aminothiol compounds |
| 09/12/2006 | US7105573 Administering to the mammal an insulin sensitivity increasing substance (ISIS) in an amount effective to treat the disorder in the mammal, in a manner so as to reach an affected area of the pilosebaceous apparatus |
| 09/12/2006 | US7105572 Cardiovascular disorders |
| 09/12/2006 | US7105571 Substituted aminoalkanoate or substituted aminoalkyl alkanoate as a penetration enhancer a shear-thinning polysaccharide, a lipophilic compound, and an acidic buffer system. |
| 09/12/2006 | US7105570 Oxidative stress inhibitor capable of suppressing the expression of a cytotoxic protein and the activation of a gene transcriptional regulatory factor taking part in such expression |
| 09/12/2006 | US7105569 Mixture of active materials; applying to fungi, or environment |
| 09/12/2006 | US7105568 Compounds for treatment of cardiac arrhythmia and methods of use |
| 09/12/2006 | US7105567 Such as N-benzyl-N'-(2,6-dimethylphenyl)-N-(4-octylphenyl)urea for treating autoimmune diseases, sepsis, adult respiratory distress syndrome, chronic obstructive pulmonary disease, allergies/asthma, atherosclerosis, and brain disorders |
| 09/12/2006 | US7105566 Administering a retinoic acid receptor (RAR) antagonist or inhibitor; reducing serum triglycerides before surgery or angioplasty |
| 09/12/2006 | US7105565 1-methyl-4-trifluoromethyl-1H-pyrrole-3-carboxylic acid [2-(1,3-dimethylbutyl)phenyl]amide; protecting plants against infestation by phytopathogenic microorganisms |
| 09/12/2006 | US7105564 7-(3-{[5-(Pyrrole-1-sulfonyl)-thiophene-2-carbonyl]-amino}-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid; thromboxane A2 receptor and a prostaglandin D2 receptor; for all of eosinophilic infiltration, advance of respiratory anaphylaxis and respiratory contraction |
| 09/12/2006 | US7105563 5-ureido-3-[(4-(3-methoxyphenyl)pyrrol-2-yl)methylene]indolin-2-one and derivatives; inhibition of phosphoinositide-dependent kinase-1 (PDK-1). |
| 09/12/2006 | US7105562 2-methyl-6-[2-oxo-1,2-dihydro-indol-(3Z)-ylidene]1,4,5,6-tetrahydro-cyclopenta[b]pyrrole-3-carboxylic acid ethyl ester; disorders related to abnormal PK activity; |
| 09/12/2006 | US7105561 Use of etodolac for the treatment of prostate cancer |
| 09/12/2006 | US7105560 Use of etodolac in the treatment of multiple myeloma |
| 09/12/2006 | US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/12/2006 | US7105558 Gastrin and cholecystokinin receptor lignads (iv) |
| 09/12/2006 | US7105557 Polymorphs of valsartan |
| 09/12/2006 | US7105556 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method |
| 09/12/2006 | US7105555 Composition of 20% BIT, 70% Polyethylene glycol, 2.1% NaOH and 7.9% water; microbiocide for latex, paint, coating, cosmetic or personal care formulations |
| 09/12/2006 | US7105554 Benzylidene thiazolidinediones and their use as antimycotic agents |
| 09/12/2006 | US7105553 Thiazolyl amide derivatives |
| 09/12/2006 | US7105552 Treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis. |
| 09/12/2006 | US7105551 Thiazole derivatives for treating PPAR related disorders |
| 09/12/2006 | US7105550 2,4-disubstituted thiazolyl derivatives |
| 09/12/2006 | US7105549 Aryl substituted pyridines and the use thereof |
| 09/12/2006 | US7105548 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 |
| 09/12/2006 | US7105547 N-{3-[3-fluoro-4-(4-oxo-3,4-dihydro-2H-pyridin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide; treating gram-negative organisms such as Haemophilus influenza and Moraxella catarrhalis. |
| 09/12/2006 | US7105546 Useful for treating or preventing neuronal damage associated with neurological diseases |
| 09/12/2006 | US7105544 N-{3-[1-(3-{[BIS(4-FLUOROPHENYL)ACETYL]AMINO}PROPYL)-4-PIPERIDINYL]PHENYL}-2-METHYLPROPANAMIDE; antagonists for melanin concentrating hormone-1 (MCH1) receptors; treating depression, anxiety, obesity |
| 09/12/2006 | US7105543 4-, 5-, 6- and 7-indole derivatives useful for the treatment of CNS disorders |
| 09/12/2006 | US7105542 Chromone compound; also viricide, antiinflammatory agents |
| 09/12/2006 | US7105541 Naphthyl compounds, intermediates, compositions, and methods of use |
| 09/12/2006 | US7105540 Cholinesterase inhibitors to treat disorders of attention |
| 09/12/2006 | US7105539 such as N-[1-Carboxy-2-(1H-indol-3-yl)-ethyl]-3-(2-mercapto-acetylamino)-succinamic acid; endopeptidase (Phex/pex) inhibitors; for promoting generation of bone mass and treating or preventing diseases or conditions associated with phosphate metabolism defect; drug screening |
| 09/12/2006 | US7105538 4-oxo-4-[2-(5-pyridin-4-yl-[1,3,4]oxadiazol-2-yl)-pyrrolidin-1-yl]-butyric acid ethyl ester; inhibition of serotonin re-uptake; analgesic effect |
| 09/12/2006 | US7105537 For enhancing bone formation; for therapy of diseases or disorders associated with abnormal bone or mineral homeostasis |
| 09/12/2006 | US7105536 Compounds |
| 09/12/2006 | US7105535 Such as n-{4-[4-(1,3-benzoxazol-2-yl)pyrazol-3-yl]phenyl}-n'-methyl urea; synthesis; cancer, cell proliferative disorders, viral infections, autoimmune diseases, neurodegenerative disorders |
| 09/12/2006 | US7105534 Imidazo[1,2-α]pyridine ether compounds as ion channel modulators |
| 09/12/2006 | US7105533 3-(3-methoxy-4-(pyridin-2-yl)phenyl)imidazo[1,5-a]pyridine hydrochloride; mGluR5 modulators treating psychiatric and mood disorders, schizophrenia, anxiety, depression, panic, pain |
| 09/12/2006 | US7105532 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 09/12/2006 | US7105531 Tricyclic protein kinase inhibitors |
| 09/12/2006 | US7105530 Pyrimidineamines as angiogenesis modulators |
| 09/12/2006 | US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy |
| 09/12/2006 | US7105528 exhibit a surprising strong efficacy in lowering the intraocular pressure; excellent duration of action; excellent tolerability |
| 09/12/2006 | US7105527 such as beta-D-N4-p-bromobenzoyl-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine; for treating human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections |
| 09/12/2006 | US7105526 Benzimidazole derivatives |
| 09/12/2006 | US7105525 6-alkoxy-pyrido-pyrimidines |
| 09/12/2006 | US7105524 2-(3,4,4-Trifluoro-but-3-enylsulfanyl)-thiazolo[5,4-b]pyridine; treating, controlling warm-blooded animals, fish and humans against infestation and infection by nematodes, helminths, arachnids and arthropod endo- and ectoparasites. |
| 09/12/2006 | US7105523 Carbamate-substituted pyrazolopyridine-derivatives |
| 09/12/2006 | US7105522 Aids therapy; viricides |
| 09/12/2006 | US7105521 1-(2 chlorophenyl-1-piperazinyl)-2-propanol-3-oxy-(2-methoxy-propenyl)-benzene; alpha 2-adrenergic/5-HT2A antagonist, 5-HT re-uptake inhibition, and anti-oxidant activities |
| 09/12/2006 | US7105520 Alpha 4 integrin antagonists |